Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Haas

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
RMD Open|November 24, 2024
Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean feverInès Elhani, Stefan Backes, Tilmann Kallinich, et al.
Arthritis Research & Therapy|April 10, 2024
Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screeningFlorian Milatz, Jens Klotsche, Martina Niewerth, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|May 31, 2022
[Recommendation for standardized medical care for children and adolescents with long COVID]Nicole Töpfner, , Martin Alberer, et al.
Pediatric Rheumatology Online Journal|March 23, 2021
Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registryElke Lainka, Melanie Baehr, Bernadette Raszka, et al.
Arthritis and Rheumatism|February 23, 2012
Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13Susan D Thompson, Miranda C Marion, Marc Sudman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2017
Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility LociLaura A McIntosh, Miranda C Marion, Marc Sudman, et al.
Arthritis Research & Therapy|December 28, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registriesJoost Swart, Gabriella Giancane, Gerd Horneff, et al.
Rheumatology (Oxford, England)|November 5, 2025
Infant-onset juvenile idiopathic arthritis - a multicenter retrospective studyTimmy Strauss, Jens Klotsche, Daniel Windschall, et al.
Clinical Immunology (Orlando, Fla.)|October 3, 2022
Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary carePrasad T Oommen, Timmy Strauss, Karen Baltruschat, et al.
ACR Open Rheumatology|January 29, 2025
Clinical Presentation and Course of Pulmonary Involvement in Chronic Nonbacterial OsteomyelitisToni Hospach, Friederike Blankenburg, Anita Heinkele, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
RMD Open|November 24, 2024
Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean feverInès Elhani, Stefan Backes, Tilmann Kallinich, et al.
Arthritis Research & Therapy|April 10, 2024
Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screeningFlorian Milatz, Jens Klotsche, Martina Niewerth, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|May 31, 2022
[Recommendation for standardized medical care for children and adolescents with long COVID]Nicole Töpfner, , Martin Alberer, et al.
Pediatric Rheumatology Online Journal|March 23, 2021
Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registryElke Lainka, Melanie Baehr, Bernadette Raszka, et al.
Arthritis and Rheumatism|February 23, 2012
Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13Susan D Thompson, Miranda C Marion, Marc Sudman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2017
Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility LociLaura A McIntosh, Miranda C Marion, Marc Sudman, et al.
Arthritis Research & Therapy|December 28, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registriesJoost Swart, Gabriella Giancane, Gerd Horneff, et al.
Rheumatology (Oxford, England)|November 5, 2025
Infant-onset juvenile idiopathic arthritis - a multicenter retrospective studyTimmy Strauss, Jens Klotsche, Daniel Windschall, et al.
Clinical Immunology (Orlando, Fla.)|October 3, 2022
Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary carePrasad T Oommen, Timmy Strauss, Karen Baltruschat, et al.
ACR Open Rheumatology|January 29, 2025
Clinical Presentation and Course of Pulmonary Involvement in Chronic Nonbacterial OsteomyelitisToni Hospach, Friederike Blankenburg, Anita Heinkele, et al.
Pageof 11